Clinical Trial Update: Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors

View source ↗

Summary

Completed clinical trial evaluating whether a trivalent influenza vaccine prevents influenza in patients with central nervous system neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Neoplasms

Drugs mentioned

• Trivalent influenza vaccine (Influenza vaccine, trivalent)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Central Nervous System Neoplasm | Status: COMPLETED